Drug intelligence / Profile preview

hydrocortisone + bacitracin zinc + neomycin sulfate + polymyxin b

Development stage
Approved
Lead developer
Pfizer
Modality
Small Molecules
Administration
Ophthalmic
01

Overview

Hydrocortisone + bacitracin zinc + neomycin sulfate + polymyxin b is a prescription **ophthalmic combination ointment** composed of three topical antibiotics and a corticosteroid. It is used for **steroid-responsive inflammatory ocular conditions** when bacterial infection is present or there is a significant risk of bacterial infection, including inflammatory conditions of the conjunctiva, cornea, and anterior segment of the globe, chronic anterior uveitis, and corneal injury from chemical, radiation, or thermal burns or foreign bodies. Hydrocortisone acts through the **glucocorticoid receptor** to suppress ocular inflammation, while bacitracin zinc inhibits bacterial cell wall synthesis, neomycin inhibits bacterial protein synthesis at the ribosome, and polymyxin b disrupts the bacterial cell envelope of susceptible organisms, together providing broad antibacterial coverage against common ocular pathogens such as *Staphylococcus aureus*, *Streptococcus pneumoniae*, *Escherichia coli*, *Haemophilus influenzae*, *Klebsiella/Enterobacter* species, *Neisseria* species, and *Pseudomonas aeruginosa*. The product is available as generic ophthalmic ointment and has historically been marketed under the Cortisporin ophthalmic brand family.

Brand names
Cortisporin
Other names
neomycin sulfate + polymyxin b sulfate + bacitracin zinc + hydrocortisone ophthalmic ointmentneomycin and polymyxin b sulfates + bacitracin zinc + hydrocortisone ophthalmic ointment
02

Targets

C55-PP (Undecaprenyl pyrophosphate)Bacterial RibosomeGR (Glucocorticoid receptor)Bacterial outer membrane lipopolysaccharide–phospholipid interface

Beyond the preview

Go deeper on hydrocortisone + bacitracin zinc + neomycin sulfate + polymyxin b.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on hydrocortisone + bacitracin zinc + neomycin sulfate + polymyxin b.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call